|
|
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse |
| 2R01DA041931-07A1 |
|
NIDA |
2022 |
|
|
DEVELOPMENT OF A SOLUBLE EPOXIDE HYDROLASE INHIBITOR TO SPARE OR REPLACE OPIOID ANALGESICS |
| 1UG3DA048767-01 |
BUCKPITT, ALAN R |
NIDA |
2019 |
|
|
DEVELOPMENT OF A COMMERCIAL PLATFORM FOR DISCOVERY AND VALIDATION OF KEY MICROBIAL METABOLITES IN CNS DISORDERS |
| 4R44DA043954-02 |
IWAI, SHOKO |
NIDA |
2019 |
|
|
MECHANISMS OF HUMAN IMMUNE MODULATION BY ORAL N-ACETYLGLUCOSAMINE |
| 5R01AT007452-05 |
DEMETRIOU, MICHAEL |
NCCIH |
2018 |
|
|
MECHANISMS OF HUMAN IMMUNE MODULATION BY ORAL N-ACETYLGLUCOSAMINE |
| 5R01AT007452-04 |
DEMETRIOU, MICHAEL |
NCCIH |
2017 |
|
|
DEVELOPMENT OF A COMMERCIAL PLATFORM FOR DISCOVERY AND VALIDATION OF KEY MICROBIAL METABOLITES IN CNS DISORDERS |
| 1R44DA043954-01 |
IWAI, SHOKO |
NIDA |
2017 |
|
|
MECHANISMS OF HUMAN IMMUNE MODULATION BY ORAL N-ACETYLGLUCOSAMINE |
| 5R01AT007452-03 |
DEMETRIOU, MICHAEL |
NCCIH |
2016 |